Paeds SAQs · investigations-procedures-and-technology
Point-of-care glucose, ketone and urinalysis testing — formative SAQs
Two MedVellum formative short-answer questions on the three core paediatric point-of-care tests: the capillary blood glucose meter and its inaccuracy in the neonate from the high haematocrit and the galactose or maltose interference with the glucose dehydrogenase strips with the rule to confirm the critical value with the laboratory plasma glucose, and the blood beta-hydroxybutyrate over the urine acetoacetate in the diabetic ketoacidosis with the ISPAD diagnostic thresholds and the falsely reassuring lagging urine ketones, plus the urine dipstick leukocyte esterase and nitrite performance in the febrile infant with the lower nitrite sensitivity and the screen-versus-culture principle. The marks and timing support transparent self-assessment. They are not an official board format or pass standard.
On this page & tools
Target exams
SAQ 1 — The neonatal glucose meter and the confirmation rule (15 marks, 15 minutes)
A two-day-old term neonate on parenteral nutrition for poor feeding has a capillary blood glucose meter reading of 1.9 mmol per litre. The meter uses a glucose dehydrogenase strip with a pyrroloquinoline-quinone cofactor. The neonate is asymptomatic. [6]
[7]Question. Describe the chemistry of the capillary glucose meter, explain why this reading may be unreliable in a neonate, state the relationship between the whole-blood and the plasma glucose, and outline the correct next steps.
[6] [7]Model answer
Strip chemistry (3 marks). The capillary blood glucose meter measures the whole-blood glucose by the glucose oxidase or the glucose dehydrogenase electrochemical strip on the capillary sample. The reaction converts the glucose to the gluconic acid and the electrons flow to the electrode to generate the current that the meter reads in five seconds. The glucose oxidase chemistry depends on the oxygen, and the glucose dehydrogenase pyrroloquinoline-quinone variant cross-reacts with the galactose, the maltose, and the xylose. [7]
Sources of error in the neonate (4 marks). The neonate is the highest-risk group for the glucose meter inaccuracy because the high haematocrit biases the reading, the variable oxygen affects the glucose oxidase chemistry, and the galactose, the maltose, or the xylose cross-reacts with the glucose dehydrogenase pyrroloquinoline-quinone strips. The parenteral nutrition and the maltose-containing products are the high-risk exposures, and the galactosaemic neonate is the classic case. The reading can be falsely high or falsely low, and the error is greatest in the neonate and the critically ill child. [6]
Whole-blood versus plasma glucose (3 marks). The capillary whole-blood glucose reads approximately ten to twelve per cent lower than the laboratory plasma glucose because the red cells contain less glucose than the plasma, and the high neonatal haematocrit widens this bias. The device may report a whole-blood or a plasma-calibrated value, and the clinician must know which. The laboratory plasma glucose is the gold standard because the plasma separation removes the haematocrit bias and the laboratory analyser has the tighter precision. [6]
Next steps (5 marks). Confirm the value with a laboratory plasma glucose before acting on the meter reading alone, and treat the symptomatic hypoglycaemia while the result is awaited. Where it is available, the interference-corrected meter such as the Nova StatStrip gives the better accuracy, the better sensitivity, and the reduced test utilisation in the neonatal intensive care. Avoid the milking or the squeezing of the heel that dilutes the sample with the tissue fluid, use the warmed heel and the free-flowing blood, and record the result with the time and the device. The general principle is that the bedside test is the first filter and the laboratory test is the arbiter. [6] [7]
You have read the opening of this SAQ. The complete unit — every section and its primary-source references — is part of the Paediatrics Fellowship fellowship atlas.
References8Show ledgerHide ledger
- [1]Glaser N, Fritsch M, Priyambada L, et al. ISPAD clinical practice consensus guidelines 2022: Diabetic ketoacidosis and hyperglycemic hyperosmolar state Pediatric Diabetes, 2022.PMID 36250645
- [2]Roberts KB Urinary tract infection: clinical practice guideline for the diagnosis and management of the initial UTI in febrile infants and children 2 to 24 months Pediatrics, 2011.PMID 21873693
- [4]Gorelick MH, Shaw KN Screening tests for urinary tract infection in children: a meta-analysis Pediatrics, 1999.PMID 10545580
- [5]St John A, Boyd JC, Lowes AJ, Price CP The use of urinary dipstick tests to exclude urinary tract infection: a systematic review of the literature American Journal of Clinical Pathology, 2006.PMID 16880133
- [6]Raizman JE, Shea J, Daly CH, et al. Clinical impact of improved point-of-care glucose monitoring in neonatal intensive care using Nova StatStrip: evidence for improved accuracy, better sensitivity, and reduced test utilization Clinical Biochemistry, 2016.PMID 27157715
- [7]Wada Y, Nakamura T, Kaneshige M, et al. Evaluation of two glucose meters and interference corrections for screening neonatal hypoglycemia Pediatrics International, 2015.PMID 25441549
- [8]Pulungan AB, Juwita E, Pudjiadi AH, et al. Diabetic ketoacidosis in adolescents and children: a prospective study of blood versus urine ketones in monitoring therapeutic response Acta Medica Indonesiana, 2018.PMID 29686175
- [10]Diviney J, Jaswon MS Urine collection methods and dipstick testing in non-toilet-trained children Pediatric Nephrology, 2021.PMID 32918601